Investing Profile

Jill carroll

Photo of Jill carroll, Principal at SR One
Your Intro Paths to Jill carroll
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
‌
Networks Jill is a member of
Duke University Network
92 CONNECTIONS

Find Jill carroll on

cb
Current Investing Position
SR One Principal
Investments On Record
7

Jill carroll's Investments On Record (5)

CompanyStageDateRound SizeTotal Raised
Avalyn Pharma
Series CSep 2023$180M
$210M
Co-investors: Robert Mittendorff (B Capital Group), Heather Preston
Odyssey Therapeutics
Series BOct 2022$170M
Series ADec 2021$220M
$490M
Co-investors: Elena Viboch (General Catalyst), Carl Gordon (OrbiMed), Lorence Kim (Third Rock Ventures)
HotSpot Therapeutics
Series CNov 2021$100M
Series BMay 2020$65M
$210M
Co-investors: Graziano Seghezzi (Soffinova Partners), Fouad Azzam (EQT Life Sciences), Bruce Booth (Atlas Venture), Ash Khanna (Pivotal bioVenture Partners)
Arch Oncology
Series AAug 2016$86M
$86M
Co-investors: Carole Nuechterlein (Roche Venture Fund), Peter Moldt (Novo Ventures), John McKearn (RiverVest)
AGTC
Series BNov 2012$38M
$38M
Co-investors: Bill Harrington (Osage University Partners), Ed Hurwitz (MPM Capital)

Jill carroll's Experience

Principal S.R. One Ltd2011 - Present
VP, Corporate Development Limerick Biopharma2010 - 2011
Sr Director, Strategic Planning & Corporate Development Dynavax Technologies2004 - 2010
Director, Market Analysis Clearview Projects2001 - 2004
Consultant Mercer Management Consulting1999 - 2001

Jill carroll's Education

Johns Hopkins University MS Biochemistry
Duke University BS Chemistry